Skip to content
The U.S. Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA) convened a joint session on drug patent systems yesterday. […]
Patent systems for drugs matter – here’s why Read More »
In 2022 drug manufacturers actually charged less for their products and patients paid slightly more than the previous year—but the cost of prescription medicines
While net drug prices drop, patients pay more thanks to health plans and PBMs Read More »
At 30-years old, the 340B program is buckling under its own weight and overdue for reform. With legal action, including a Supreme Court ruling,
The 30-year-old 340B drug discount program is due for reform Read More »
The United States and the Biotechnology Innovation Organization (BIO) have been taking action in light of ongoing negotiations concerning extending the Trade-Related Aspects of
What’s happening with the COVID IP waiver expansion? Read More »
The Senate on Wednesday confirmed Alexis Taylor to become the U.S. Department of Agriculture (USDA) undersecretary for trade and foreign agricultural affairs. The USDA
Senate confirms Alexis Taylor as USDA trade undersecretary Read More »
The text of the 4,155-page, $1.7 trillion omnibus spending bill was delivered around 2 a.m. Tuesday. According to POLITICO, the Senate is “scrambling” to
What’s in the government’s omnibus spending package Read More »
It’s no surprise the COVID-19 pandemic aggravated the United States’ already rampant opioid epidemic. But what’s more surprising, and devastating, has been the increase
Teen opioid deaths are on the rise – but OTC Narcan could help Read More »
The federal government today released two calls for public input on how the U.S. can support biotech innovation to help strengthen the industry while
Biden Administration seeks public input on how to support biotech Read More »
The Accelerated Approval (AA) pathway, one of the U.S. Food and Drug Administration’s (FDA) most valuable tools that allow drugs to launch in the
FDA cuts back on Accelerated Approval pathway in 2022 Read More »
The 2022 midterms are officially behind us – so, what happened, and what does biotech need to know going into the new year? We
2022 midterms recap: what happened and what the results mean for biotech Read More »
